IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MFN Partners Management, LP

Q3 2019 Holdings

Filed 2019-11-14 | 14 holdings | $2.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$1.6M1,500,00070.8%
Allergan PLCSHSG0177J108$235.6K1,400,10110.3%
FOX Corp(FOXA)CL A COM35137L105$74.7K2,369,3313.3%
Liberty Global PLCSHS CL CG5480U120$71.4K3,000,0003.1%
Cheniere Energy Inc(LNG)COM NEW16411R208$66.2K1,050,0002.9%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$55.3K6,439,5412.4%
XPO Logistics Inc(XPO)COM983793100$50.1K700,0002.2%
Pioneer NAT RES Co(PXDEUR)COM723787107$33.1K263,5001.4%
PG&E Corp(PCG)COM69331C108$28.0K2,800,0001.2%
FGL HldgsORD SHSG3402M102$23.1K2,896,1861.0%
Cyclerion Therapeutics Inc(CYCNUSD)COM23255M105$18.0K1,487,8740.8%
GTT Communications IncCOM362393100$9.2K981,1430.4%
Evolus Inc(EOLS)COM30052C107$1.9K120,0000.1%
Revance Therapeutics Inc(RVNCEUR)COM761330109$59846,0000.0%